Anixa Biosciences gets notice of allowance for patent application for its ovarian cancer vaccine technology from USPTO: San Jose, California Thursday, March 27, 2025, 17:00 Hrs [I ...
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.
Anixa Biosciences, Inc. (NASDAQ:ANIX) entered into a letter of intent with VERDI Solutions GmbH to develop personalized and ...
On Monday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a key patent application ...
Monitoring Anti-Müllerian Hormone (AMH) levels can provide essential insights into ovarian reserve and fertility, aiding in informed decisions about family planning and potential fertility ...
“Had I known earlier, I think I would have made different decisions that would have benefited me very differently now.” Kelly ...